Skip to main content

Albemarle Corporation

corporate_fare Company Profile

Albemarle Corporation

ALB·NYSE·Industrial Applications And Services·CIK 0000915913

Albemarle Corporation transforms essential resources into critical ingredients for mobility, energy, connectivity, and health. The company serves end markets such as grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals, and medical devices. As of December 31, 2025, Albemarle served approximately 1,900 customers in approximately 70 countries. Albemarle and its joint ventures operate more than 25 production and research and development facilities globally, along with administrative and sales offices. During 2025, the company managed its operations under three reportable segments: Energy Storage, Specialties, and Ketjen. These segments are organized based on similar markets, customers, economic characteristics, and production processes. On October 25, 2025, Albemarle signed an agreement to divest the controlling ownership interest of Ketjen's Refining Solutions business to ChemCat AcquisitionCo, LLC. The remaining ownership interest will be contributed to ChemCat Holdings, LP, a newly formed limited partnership. The divested and contributed Refining Solutions business is defined as the Ketjen reportable segment, excluding its PCS business and Albemarle's 50% ownership interest in Eurecat S.A.

Albemarle Corporation (NYSE:ALB) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 26 items for ALB at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Albemarle Upsizes Debt Tender Offer Cap to $650M, Announces Strong Early Participation
  • Albemarle Proposes New Equity Incentive Plan and Governance Enhancements for Annual Meeting
  • Albemarle Completes Major Asset Sale, Initiates $1.15B Debt Reduction Program
  • Albemarle Appoints Two Highly Experienced Independent Directors to Board
  • Albemarle Reports Full-Year 2025 Results, Details Ketjen Divestiture & New Kemerton Plant Shutdown

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$5.14B
Net Income
-$510.63M
Diluted EPS
-$5.76
Op. Cash Flow
$1.28B
Free Cash Flow
$692.47M
Gross Profit
$668.72M
Operating Income
-$367.08M
Cash & Equivalents
$1.62B
Total Debt
$3.19B
Debt / Equity
0.33×
Net Margin
-9.9%
Shares Outstanding
117.72M sh
Source: 10-K · filed 2026-03-31 · accession 0000915913-26-000060
$118 +0.48% today
52-week range · as of 2026-09-03 $71.25 – $221
Market cap
$13.87B
Volume
2.4M (1.0× avg)
3-mo avg 2.3M
Live data · 2026-09-14 04:43 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed ALB - Filings & News (Page 2)

ALB
Mar 16, 2026, 6:50 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $160.37
Real-time Price: $118.00 info
Change: -$42.37 (-26%) info
Market Cap: $13.868B info
ALB
Mar 11, 2026, 4:32 PM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $166.31
Real-time Price: $118.00 info
Change: -$48.31 (-29%) info
Market Cap: $13.868B info
ALB
Mar 06, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $162.54
Real-time Price: $118.00 info
Change: -$44.54 (-27%) info
Market Cap: $13.868B info
ALB
Mar 04, 2026, 4:23 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $168.51
Real-time Price: $118.00 info
Change: -$50.51 (-30%) info
Market Cap: $13.868B info
ALB
Feb 11, 2026, 4:49 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $171.99
Real-time Price: $118.00 info
Change: -$53.99 (-31%) info
Market Cap: $13.868B info
ALB
Feb 11, 2026, 4:23 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $164.98
Real-time Price: $118.00 info
Change: -$46.98 (-28%) info
Market Cap: $13.868B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets